Department of Molecular Biology and Genetics, Aarhus University, Aarhus, Denmark.
Nanoscale. 2019 Jan 3;11(2):587-597. doi: 10.1039/c8nr07850e.
In the current study, we describe a novel DNA sensor system for specific and quantitative detection of mycobacteria, which is the causative agent of tuberculosis. Detection is achieved by using the enzymatic activity of the mycobacterial encoded enzyme topoisomerase IA (TOP1A) as a biomarker. The presented work is the first to describe how the catalytic activities of a member of the type IA family of topoisomerases can be exploited for specific detection of bacteria. The principle for detection relies on a solid support anchored DNA substrate with dual functions namely: (1) the ability to isolate mycobacterial TOP1A from crude samples and (2) the ability to be converted into a closed DNA circle upon reaction with the isolated enzyme. The DNA circle can act as a template for rolling circle amplification generating a tandem repeat product that can be visualized at the single molecule level by fluorescent labelling. This reaction scheme ensures specific, sensitive, and quantitative detection of the mycobacteria TOP1A biomarker as demonstrated by the use of purified mycobacterial TOP1A and extracts from an array of non-mycobacteria and mycobacteria species. When combined with mycobacteriophage induced lysis as a novel way of effective yet gentle extraction of the cellular content from the model Mycobacterium smegmatis, the DNA sensor system allowed detection of mycobacteria in small volumes of cell suspensions. Moreover, it was possible to detect M. smegmatis added to human saliva. Depending on the composition of the sample, we were able to detect 0.6 or 0.9 million colony forming units (CFU) per mL of mycobacteria, which is within the range of clinically relevant infection numbers. We, therefore, believe that the presented assay, which relies on techniques that can be adapted to limited resource settings, may be the first step towards the development of a new point-of-care diagnostic test for tuberculosis.
在当前的研究中,我们描述了一种用于结核分枝杆菌(引起结核病的病原体)的特异性和定量检测的新型 DNA 传感器系统。检测是通过利用分枝杆菌编码的酶拓扑异构酶 IA(TOP1A)的酶活性作为生物标志物来实现的。本工作首次描述了如何利用 I 型拓扑异构酶家族成员的催化活性来特异性检测细菌。检测的原理依赖于带有双重功能的固相亲和 DNA 底物:(1)从粗提样品中分离分枝杆菌 TOP1A 的能力;(2)与分离的酶反应后转化为闭合 DNA 环的能力。DNA 环可作为滚环扩增的模板,产生串联重复产物,通过荧光标记可在单分子水平上可视化。该反应方案确保了分枝杆菌 TOP1A 生物标志物的特异性、敏感性和定量检测,这一点通过使用纯化的分枝杆菌 TOP1A 和来自多种非分枝杆菌和分枝杆菌物种的提取物得到了证明。当与分枝杆菌噬菌体诱导裂解相结合作为一种从模型分枝杆菌耻垢分枝杆菌中有效而温和地提取细胞内容物的新方法时,该 DNA 传感器系统允许在小体积的细胞悬浮液中检测分枝杆菌。此外,还可以检测到人唾液中添加的分枝杆菌。根据样品的组成,我们能够检测到每毫升分枝杆菌 0.6 或 0.9 百万个菌落形成单位(CFU),这处于临床相关感染数量的范围内。因此,我们认为,这种依赖于可以适应有限资源环境的技术的检测方法,可能是开发新的即时护理结核病诊断测试的第一步。